Catherine E. Winbanks

75 Commercial Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart.

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 10, 2021

Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia.

Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia.

Journal: Science translational medicine
Published: August 01, 2019

Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.

Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.

Journal: Scientific reports
Published: July 02, 2015

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

Journal: Clinical science (London, England : 1979)
Published: June 15, 2015

Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.

Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.

Journal: Science translational medicine
Published: May 04, 2015

The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.

The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.

Journal: Nature communications
Published: August 29, 2014

MicroRNAs differentially regulated in cardiac and skeletal muscle in health and disease: potential drug targets?

MicroRNAs differentially regulated in cardiac and skeletal muscle in health and disease: potential drug targets?

Journal: Clinical and experimental pharmacology & physiology
Published: March 31, 2014

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.

Journal: PloS one
Published: December 22, 2013

The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.

The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.

Journal: The Journal of cell biology
Published: October 23, 2013

miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4.

miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4.

Journal: PloS one
Published: December 26, 2012

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 11, 2012

Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammation.

Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammation.

Journal: PloS one
Published: August 10, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026